Suppr超能文献

下斜肌肉毒杆菌毒素注射在下斜肌切除术之前是一种有效的手术模拟器吗?一项30年的回顾性研究。

Is inferior oblique botulinum toxin injection an effective surgical simulator prior to inferior oblique myectomy? A 30-year retrospective review.

作者信息

Norbury Christopher, Shah Haider, Marsh Ian

机构信息

Ophthalmology Department, Aintree University Hospital, Liverpool, UK.

出版信息

Strabismus. 2025 Sep;33(3):166-173. doi: 10.1080/09273972.2025.2452623. Epub 2025 Jan 24.

Abstract

Botulinum toxin A (BTX) injected into the inferior oblique muscle temporarily simulates the post-operative effect of an inferior oblique myectomy (IOM). This can aid in surgical planning, especially given the irreversible nature of IOM. This study evaluates the efficacy of BTX as a pre-operative simulator and compares its effects to those of IOM. To our knowledge, this is the largest reported series of patients undergoing pre-operative BTX simulations, prior to IOM. : A retrospective review was conducted on all patients receiving inferior oblique BTX between 1 January 1994 and 1 January 2024, by a single surgeon using an electromyography-guided technique. Data, including diagnosis, procedure, and orthoptic measurements, were obtained from electronic and archived paper records. Successful outcome was defined as subjective improvement in symptoms, or objectively as, reduction of vertical angle deviation in primary position by at least 50%, or post-procedure vertical deviation in primary position of ≤5 Prism Dioptres (PD). : Sixty-eight patients underwent inferior oblique BTX within the study period. Of these, 48/68 patients (71%) had an improvement in subjective symptoms. Subsequently, 36/48 patients (78%) underwent IOM, 4/48 (8%) patients are awaiting IOM, 4/48 (8%) patients requested repeat BTX despite IOM being offered, and 4/48 (8%) patients had complete resolution with no further intervention. Following IOM, 34/36 (94%) achieved the defined successful outcome, with no significant difference between vertical deviation measurements following BTX or IOM ( < .05). No post-operative diplopia or other complications were identified, and 3/36 (8%) patients demonstrated an asymptomatic over-correction. BTX was deemed unsuccessful in 20 patients (29%). Within this cohort, 12 had no improvement (despite repeat treatment with a higher dose), 3 patients were lost to follow-up, 1 patient died and 4 patients developed problematic diplopia in the primary position, which resolved when the BTX wore off. : Inferior oblique BTX is a useful and reliable tool for IOM simulation, prior to irreversible surgery. Its temporary effect on vertical deviation in primary position is comparable to IOM, and can also be used as a tool to identify patients at risk of diplopia, or failure of treatment.

摘要

将A型肉毒杆菌毒素(BTX)注射到下斜肌中可暂时模拟下斜肌切除术(IOM)的术后效果。这有助于手术规划,特别是考虑到IOM的不可逆性。本研究评估了BTX作为术前模拟剂的疗效,并将其效果与IOM的效果进行比较。据我们所知,这是报道的在IOM之前接受术前BTX模拟的患者中规模最大的系列研究。:对1994年1月1日至2024年1月1日期间由一名外科医生使用肌电图引导技术接受下斜肌BTX治疗的所有患者进行了回顾性研究。数据,包括诊断、手术和视光学测量,从电子和存档纸质记录中获取。成功结果定义为主观症状改善,或客观上定义为原在位垂直角度偏差减少至少50%,或术后原在位垂直偏差≤5棱镜度(PD)。:在研究期间,68例患者接受了下斜肌BTX治疗。其中,48/68例患者(71%)主观症状有改善。随后,36/48例患者(78%)接受了IOM,4/48例患者(8%)正在等待IOM,4/48例患者(8%)尽管已提供IOM仍要求重复BTX治疗,4/48例患者(8%)未经进一步干预症状完全缓解。IOM后,34/36例患者(94%)达到了定义的成功结果,BTX或IOM后垂直偏差测量结果之间无显著差异(<0.05)。未发现术后复视或其他并发症,3/36例患者(8%)表现为无症状性过度矫正。20例患者(29%)的BTX治疗被认为不成功。在该队列中,12例患者无改善(尽管用更高剂量重复治疗),3例患者失访,1例患者死亡,4例患者在原在位出现有问题的复视,当BTX作用消失后复视缓解。:在下斜肌进行不可逆手术之前,下斜肌BTX是一种用于IOM模拟的有用且可靠的工具。其对原在位垂直偏差的暂时影响与IOM相当,也可作为识别有复视风险或治疗失败患者的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验